Method of treatment using organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1α
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 19, 2014
Issued Date -
N/A
app pub date -
Aug 1, 2011
filing date -
Apr 30, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to in vitro cultured skin tissue, and in particular to cultured skin tissue comprising exogenous genes encoding angiogenic growth factors. In some embodiments, the keratinocytes express exogenous angiopoietin-1, HIF-1α, or a member of the VEGF family, preferably VEGF-A. In particularly preferred embodiments, the keratinocytes are incorporated into cultured skin tissue.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully